Imagine if Amarantus sees similar success as Amgen. In the 1990s, Amgen split 5 times.
For every 1 share held at the beginning of the decade, the shareholder would hold 48 shares at the end of the decade.
http://getsplithistory.com/AMGN
I see a strong possibility for similar results with Amarantus, so as a long-term investor, the impact of a RS to uplist is less of a concern to me, although I do support as small a RS as needed, and I'm holding the company to their repeated assurances that a large RS will not be done from the current valuation.
For every 1 share held at the beginning of the decade, the shareholder would hold 48 shares at the end of the decade.
http://getsplithistory.com/AMGN
I see a strong possibility for similar results with Amarantus, so as a long-term investor, the impact of a RS to uplist is less of a concern to me, although I do support as small a RS as needed, and I'm holding the company to their repeated assurances that a large RS will not be done from the current valuation.
